Life Sciences
Clade Therapeutics, Inc.
Year
2022
Clade's platform technology immune “cloaks” human pluripotent stem cells and their adult derivatives enabling the development of true ‘off-the-shelf’ cell transplantation therapies.
Website
Company Status
Active
U of A Inventors
Deepta Bhattacharya
Hannah Pizzato
College
College of Medicine - Tucson, BIO5 Instutute, UArizona Cancer Center